NCT01690871 A Phase II Study of Orally Administered BEZ235 Monotherapy in Patients With Metastatic or Unresectable Malignant PEComa Status WITHDRAWN Phase PHASE2
NCT01688882 Safety, Efficacy and PK/PD of QGE031 vs. Placebo in Patients With Active Bullous Pemphigoid Despite Oral Steroid Treatment Status TERMINATED Phase PHASE2
NCT01686932 Vildagliptin vs Sitagliptin add-on to Insulin - Impact on Glycemic Profile and Correlation of Hypoglycemic Episodes and Heart Function Status COMPLETED Phase PHASE4
NCT01685138 LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT01685060 LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib Status COMPLETED Phase PHASE2
NCT01682863 A Multi-centre Randomized Double Blind 52-week Study to Assess the Safety of QVA149 Compared to QAB149 in Patients With COPD Who Have Moderate to Severe Airflow Limitation Status COMPLETED Phase PHASE3
NCT01682083 Dabrafenib With Trametinib in the Adjuvant Treatment of High-risk BRAF V600 Mutation-positive Melanoma (COMBI-AD). Status COMPLETED Phase PHASE3
NCT01681576 Assessment of LCZ696 and Valsartan in Asian Patients With Salt-sensitive Hypertension Status COMPLETED Phase PHASE2
NCT01680796 Dovitinib Combined With Bortezomib and Dexamethasone for Relapsed/Refractory Multiple Myeloma Status WITHDRAWN Phase PHASE1
NCT01678105 A Phase II Study of Dovitinib in Recurrent and/or Metastatic Adenoid Cystic Carcinoma of the Salivary Glands Status COMPLETED Phase PHASE2
NCT01677741 A Study to Determine Safety, Tolerability and Pharmacokinetics of Oral Dabrafenib In Children and Adolescent Subjects Status COMPLETED Phase PHASE1/PHASE2
NCT01676948 An Open-label, Multi-arm, Non-comparative Safety and Tolerability Study of Canakinumab (ACZ885) in Patients With Active Systemic Juvenile Idiopathic Arthritis (SJIA) Status WITHDRAWN Phase PHASE3
NCT01673646 Efficacy and Safety of Pasireotide LAR (Long-acting Release) in Japanese Patients With Acromegaly or Pituitary Gigantism Status COMPLETED Phase PHASE2
NCT01669174 BYM338 in Chronic Obstructive Pulmonary Disease (COPD) Patients With Cachexia Status COMPLETED Phase PHASE2
NCT01665768 Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma Status COMPLETED Phase PHASE2
NCT01665144 Exploring the Efficacy and Safety of Siponimod in Patients With Secondary Progressive Multiple Sclerosis (EXPAND) Status COMPLETED Phase PHASE3
NCT01663233 Efficacy and Safety of LCZ696 200 mg + Amlodipine 5 mg in Comparison With Amlodipine 5 mg in Hypertensive Patients Not Responding to Amlodipine Status COMPLETED Phase PHASE3
NCT01661283 SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors Status COMPLETED Phase PHASE2
NCT01660295 Pharmacokinetics of Certoparin in Subjects With Renal Insufficiency and Healthy Subjects Status COMPLETED Phase PHASE1/PHASE2